As the Senior Director of Competitive Intelligence at AstraZeneca, Emir Roach leverages his extensive background in consulting and life sciences to drive strategic initiatives within the GU&GYN therapeutic area. With a foundation built on his experiences at McKinsey and BCG, Emir brings a unique blend...
As the Senior Director of Competitive Intelligence at AstraZeneca, Emir Roach leverages his extensive background in consulting and life sciences to drive strategic initiatives within the GU&GYN therapeutic area. With a foundation built on his experiences at McKinsey and BCG, Emir brings a unique blend of analytical rigor and industry insight to his role. He is instrumental in shaping the solid tumor portfolio strategy, ensuring that AstraZeneca remains at the forefront of innovation in oncology.
Emir collaborates closely with cross-functional teams, including Research & Development, Business Development, Medical Affairs, and Commercial leaders, to align competitive intelligence efforts with broader organizational goals. His expertise in due diligence and strategic planning is critical in supporting business development and licensing priorities, where he plays a key role in search and evaluation processes. By informing commercial positioning and messaging, Emir helps to refine forecasting assumptions that guide AstraZeneca's market approach.
Moreover, Emir's insights extend to external academic engagements and evidence generation plans, where he helps to bridge the gap between clinical research and commercial strategy. His ability to synthesize complex data and translate it into actionable intelligence empowers AstraZeneca to make informed decisions that enhance patient outcomes. With a skill set that includes healthcare management, medical education, and event planning, Emir is dedicated to fostering a culture of collaboration and innovation, ensuring that AstraZeneca not only meets the current demands of the healthcare landscape but also anticipates future challenges in the life sciences sector.
